Skip to content

Intensification of Care to Improve Adherence to Anti-hypertensives

Intensification of Care to Improve Adherence to Anti-hypertensives in Primary Care: a Pragmatic Clinical Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01331369
Acronym
HyperCare
Enrollment
243
Registered
2011-04-08
Start date
2010-11-30
Completion date
2012-04-30
Last updated
2017-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication Adherence

Keywords

adherence, compliance, persistence, drop out, abandon

Brief summary

The aim of the study is to evaluate the effectiveness of a social-psychological intervention to improve anti-hypertensives adherence in primary care. Its is a pragmatic clinical trial.

Detailed description

We will study two groups of 198 people with hypertension treated in ten health care units. One group will receive usual care dispensed in units (control). The other group (intervention) will be offered six individual assistance with health care worker physician or nurse) during the period of 9 months with a minimum interval of 30 days, plus 9 monthly visits structured by community health agents. Adherence will be measured in both groups at baseline and months 3, 6, 9 and 12, through validated questionnaire and pill count. Also evaluated clinical outcome measures (blood pressure, hospitalizations and deaths). The analysis will be done by intention to treat comparing adherence measures and clinical outcome between groups (Student t test and chi-square test) and within groups over time (paired t test and McNemar). It will be accepted p value \<0.05.

Interventions

BEHAVIORALIntensification of Care

Usual provided care plus social-psychological intervention: 6 consultation with doctors and 9 with community health workers, both oriented by protocol.

OTHERUsual Care

Usual care provided (medical and/or nurse consultation and medicines)

Sponsors

Fundacao de Apoio a Pesquisa de Santa Catarina
CollaboratorUNKNOWN
Universidade de Blumenau
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* persons with hypertension aged 18 years and older

Exclusion criteria

* those with physical or mental impaired that cannot go to health care units or cannot answer a questionnaire * pregnants

Design outcomes

Primary

MeasureTime frameDescription
Change in the proportion of people adherent to treatment - MMAS-8at basal and 3, 6, 9 and 12 monthsIt will be measure by Moriski Medication Adherence Scale 8 item, translated and validated in Brazil. MMAS scores were trichotomized previously into the following 3 levels of adherence: high adherence (score, 8), medium adherence (score, 6 to \<8), and low adherence (score, \<6).

Secondary

MeasureTime frameDescription
Change in the proportion of people adherent to treatment - QAM-Qat basal and 3, 6, 9 and 12 monthsIt will be measure by Questionário de Adesão a Medicamentos -Qualiaids 3 item, an structured questionnaire developed and validated in Brazil. Non-adherence was accepted if respondent doesn't take 80% of his medicines or if he/she presents any errors on the process (time, jumps..)
Means difference and/or risk ratio between and within groups of clinical outcomesat basal and 3, 6, 9 and 12 monthsIt will be evaluated mean blood pressure, proportion of complications, hospitalization and death in each group.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026